Mandel-Brehm Josh 4
4 · Camp4 Therapeutics Corp · Filed Sep 11, 2025
Insider Transaction Report
Form 4
Mandel-Brehm Josh
DirectorChief Executive Officer
Transactions
- Purchase
Common Stock
2025-09-11$1.65/sh+6,060$9,999→ 278,417 total
Footnotes (1)
- [F1]On September 11, 2025, the reporting person acquired shares in a private placement by the Issuer pursuant to the terms of a Securities Purchase Agreement, dated as of September 9, 2025, by and among the Issuer and certain institutional investors and certain directors, employees, and consultants, at a purchase price of $1.65 per share.